Document is current
Any future updates will be listed below
-
Authors
Lampropoulou-Adamidou, Kalliopi https://orcid.org/0000-0003-3434-6053
Trovas, Georgios https://orcid.org/0000-0002-6702-650X
Triantafyllopoulos, Ioannis K. https://orcid.org/0000-0002-1451-2379
Yavropoulou, Maria P. https://orcid.org/0000-0002-6501-3692
Anastasilakis, Athanasios D. https://orcid.org/0000-0002-9624-6296
Anagnostis, Panagiotis https://orcid.org/0000-0002-8949-4312
Toulis, Konstantinos A. https://orcid.org/0000-0002-2044-4253
Makris, Konstantinos https://orcid.org/0000-0002-7896-9028
Gazi, Sousana https://orcid.org/0000-0002-3151-2055
Balanika, Alexia https://orcid.org/0000-0003-0971-6390
Tournis, Symeon https://orcid.org/0000-0002-8301-324X
- License Information
-
More Information
Article History
Received: 11 April 2021
Accepted: 31 May 2021
First Online: 16 June 2021
Declarations
:
: KLA has received lecture fees from Amgen, GT has received lecture and/or advisory board fees from Amgen, Eli Lilly, ELPEN, ITF Hellas, VIANEX, LIBYTEC, Galenica, Merck Biopharma, MPY has received lecture fees from Galenica, Shire, and Eli Lilly, ADA has received lecture fees from Amgen, Eli Lilly, ELPEN, ITF Hellas, and VIANEX; ST has received lecture and/or advisory board fees from Amgen, Eli Lilly, VIANEX, ITF Hellas, LIBYTEC, Merck Biopharma Greece, Galenica, and Shire. IIT, PA, KAT, MK, SG and AB have nothing to disclose.
: The study was approved by the ethics committee of KAT General Hospital. All procedures were conducted according to the recommendations of Good Clinical Practice and all other applicable local regulatory and ethical requirements and the Declaration of Helsinki (revised edition, Tokyo 2004).
: Written informed consent was obtained from all patients.
